Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > New Press Release - Sirona Biochem Announces Close of Oversubscribed Debenture Financing

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Apr 20, 2023 7:17pm

60 Views

Post# 35406328

RE:RE:New Press Release - Sirona Biochem Announces Close of Oversubscribed Debenture Financing

navajojoe wrote: So Howie took a third of this financing (that should have never been needed if we hadn't gotten screwed by Abbvie).
Not much risk taken by looking at the terms, but lots of upside for him if things work out.
Too bad it wasn't offered to shareholders.

So where does the fine Doctor come up with $500,000 for this purchase? Does a local Dr. make that kind of bucks? He would have to sell 5 million shares of SBM at 10 cents to raise $500K for the debenture.???

<< Previous

Bullboard Posts

Next >>

Three mispriced stocks exposed to major market tailwinds